QNCX

Quince Therapeutics, Inc. Common Stock

$1.15 -1.71%

Recent alerts on QNCX

All signals →

Short volume Short volume 65% of volume (4.2σ)

SEC filing QNCX Reports Phase 2a LAM-001 Trial Success, +67.4m 6MWD, -33.9% PVR in PH-ILD Patients, Plans Phase 2b Mid-2026

News Quince announces acquisition of Orphai and up to $187M private placement to advance pulmonary pipeline

SEC filing QNCX Regains $1.00 Bid Price Compliance, 10-Day Streak, Nasdaq Notice; Still Faces $50M MVLS Challenge Until Sept 2026

SEC filing QNCX Delisted: $1.00 Bid Price Rule Missed, $50M MVLS Below Nasdaq Minimum, 180-Day Cure Window Ends Sept 14 2026

SEC filing 8-K Filing

Scanner Unusual volume (2.2x average)

News Quince Partners Exclusively with A$AP Rocky on DON'T BE DUMB Vinyl and Limited-Edition Apparel

Get push alerts for QNCX

Add it to your watchlist in the app and receive every signal the moment it fires.

Download for iOS

Download for iOS